CMPX compared with FULC: revenue, margins and what each company keeps, and the suppliers and customers both name

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

FULCFulcrum Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CMPXCompass Therapeutics, Inc.

FULCFulcrum Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CMPX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+5.29%—

May 5 '26±16.1%▲+0.52%×0.03

Q1 FY26±52.0%▼−2.81%×0.05

Jan 6 '26±33.6%▼−1.60%×0.05

FULC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q1 FY26±19.3%▼−1.53%×0.08

Feb 24 '26±29.8%▼−21.21%×0.71

= impliedCMPX realized, solidFULC realized, hatchedOne scale, both sides: full bar = 53%× = |realized| ÷ impliedSource: market data

Oct 29 '25

±18.7%

▼−6.40%

×0.34

Jul 29 '25±44.9%▼−2.82%×0.06

CMPXCompass Therapeutics, Inc.

0.79· pre 0.80

Mkt cap$141.6MRevenue$850,000Q2 FY24

FULCFulcrum Therapeutics, Inc.

3.71· pre 3.71· delayed

Pre-marketSep 2 '83

Mkt cap$283.1MRevenue$80MQ2 FY24

Compare

Pre-marketSep 2 '83

CMPXCompass Therapeutics, Inc.

FULCFulcrum Therapeutics, Inc.

0.79pre 0.80

Price

3.71pre 3.71delayed

$141.6M

Mkt cap

$283.1M

Q2 FY24$850,000

Revenue

$80MQ2 FY24

CMPX0.79vsFULC3.71Pre-marketSep 2 '83